Investor Centre Faces Trading Suspension After Funding Collapse

Funding Shock Triggers Reporting Delay

Investor Centre Limited (ASX – ICU) has announced a delay in releasing its Appendix 4E and Annual Report for the financial year ended 30 June 2025. The postponement stems from the unexpected liquidation of Amram Corp Pty Ltd, the company’s primary funding provider. This development has compelled ICU and its auditor, Hall Chadwick, to take additional time to evaluate the company’s financial viability and going concern status.

Assessing Going Concern Amid Uncertainty

The liquidation of Amram Corp has introduced significant uncertainty into ICU’s financial outlook. The company must now rigorously assess whether it can continue as a going concern without the support of its former funder. This process involves detailed financial scrutiny and the exploration of alternative funding avenues to bridge the gap left by Amram’s exit.

Implications for Shareholders and Market

As a result of the delay, ICU anticipates being placed into a compulsory trading suspension starting 1 September 2025 due to non-lodgement of its statutory reports by the ASX deadline. This suspension will restrict trading in ICU shares, potentially heightening investor anxiety. The company has committed to keeping shareholders informed as it navigates this challenging period.

Looking Ahead – Funding and Recovery

ICU’s immediate priority is securing alternative funding to satisfy its going concern requirements and resume normal reporting. The outcome of these efforts will be critical in determining the company’s financial stability and future market performance. Investors will be watching closely for updates on funding arrangements and the eventual release of the delayed financial statements.